Keywords
How to Cite
Abstract
Мақсад: Ушбу тадқиқот суv чечак (ветряная оспа / Varicella zoster) касаллигининг клиник-эпидемиологик хусусиятларини ўрганиш, ҳозирги замон диагностика мезонларини такомиллаштириш ва даволаш протоколларини баҳолашга бағишланган.
References
1.Ваrаff LJ, Ward JI. Varicella — epidemiology and clinical features. Pediatrics. 2021; 148(3): e2021051946.
2.WHO Global Varicella Report. World Health Organization, Geneva. 2023; 56–74 p.
3.Ўзбекистон Республикаси Соғлиқни сақлаш вазирлиги. Юқумли касалликлар статистикаси. Тошкент, 2024.
4.Nair PA, Vora RV, Jivani NB. Herpes zoster following varicella vaccination. Indian J Dermatol. 2022; 67(2):112–115.
5.Мирзаев Ш.Б. Ҳомиладорларда суv чечак клиник-лаборатор хусусиятлари. Ўзбекистон тиббиёт журнали. 2023; 4:18–23.
6.Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015; 1: 15016.
7.Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster. BMJ Open. 2014; 4(6): e004833.
8.Каримова Г.Р., Тошматов А.Х. Болаларда суv чечак кечиши хусусиятлари. Педиатрия. 2022; 3:45–50.
9.Seward JF, Watson BM, Peterson CL. Varicella disease after introduction of varicella vaccine. JAMA. 2021; 287(5): 606–611.
10.Gupta S, Trivedi D, Sinha P. Clinical profile and complications of varicella. Int J Dermatol. 2020; 59(8): 962–968.
11.Hall S, Maupin T, Seward J, et al. Second varicella infections: are they more common than previously thought? Pediatrics. 2022; 109(6): 1034–1039.
12.Levin MJ, Dahl KM, Weinberg A. Development of resistance to acyclovir during chronic infection with VZV. J Infect Dis. 2003; 188(7): 954–959.
This work is licensed under a Creative Commons Attribution 4.0 International License.